Phase II Trial of MEK Inhibitor Binimetinib (MEK162) in RAS-mutant Acute Myeloid Leukemia
Titel:
Phase II Trial of MEK Inhibitor Binimetinib (MEK162) in RAS-mutant Acute Myeloid Leukemia
Auteur:
Maiti, Abhishek Naqvi, Kiran Kadia, Tapan M. Borthakur, Gautam Takahashi, Koichi Bose, Prithviraj Daver, Naval G. Patel, Ami Alvarado, Yesid Ohanian, Maro DiNardo, Courtney D. Cortes, Jorge E. Jabbour, Elias J. Garcia-Manero, Guillermo Kantarjian, Hagop M. Ravandi, Farhad